InvestorsHub Logo
Followers 53
Posts 1782
Boards Moderated 0
Alias Born 03/22/2015

Re: senderos post# 290007

Tuesday, 05/29/2018 10:41:09 AM

Tuesday, May 29, 2018 10:41:09 AM

Post# of 402223

Elite Pharmaceuticals, Inc ( ELTP ) announced today the signing of a license, manufacturing, and supply agreement with Glenmark Pharmaceuticals, Inc., USA to market two Elite generic products in the United States with the option to add products in the future.








Interesting. We've discussed Glenmark before. They were the ones who sponsored Lehigh Valley Pharma efforts to get an NDA for oxycodone 5mg capsules via the 505b2 pathway. Small world, eh? (Or maybe not.)







https://investorshub.advfn.com/boards/read_msg.aspx?message_id=124579915



Next I started trying to track down the fed Tmax for oxycodone tablets, and it turns out that it is not public information, as far as I can find. But! I did find the fed Tmax for oxycodone capsules! I don’t understand the full history of how this happened, but somehow along the way a bunch of generic manufacturers started making oxycodone 5mg in capsule form and oxycodone solution with a different manufacturing technique. They were doing this without proper approvals and the FDA swept them all off the shelf at once, similar to what they did to us with Lodrane. Lehigh Valley (with Glenmark Pharmaceuticals) subsequently received approval for their two products via 505b2 NDA’s for a 5mg capsule- and a second NDA for oral solution. Both NDA’s use Roxicodone as a reference product.







Call on God but row away from the rocks.

-Hunter S. Thompson

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News